O. E. Anastasiou Et Al. , "Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D," Liver International , vol.44, no.1, pp.139-147, 2024
Anastasiou, O. E. Et Al. 2024. Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D. Liver International , vol.44, no.1 , 139-147.
Anastasiou, O. E., Caruntu, F. A., Curescu, M. G., Yalcin, K., Akarca, U. S., GÜREL, S., ... Zeuzem, S.(2024). Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D. Liver International , vol.44, no.1, 139-147.
Anastasiou, Olympia Et Al. "Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D," Liver International , vol.44, no.1, 139-147, 2024
Anastasiou, Olympia E. Et Al. "Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D." Liver International , vol.44, no.1, pp.139-147, 2024
Anastasiou, O. E. Et Al. (2024) . "Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D." Liver International , vol.44, no.1, pp.139-147.
@article{article, author={Olympia E. Anastasiou Et Al. }, title={Five-year follow-up of 96 weeks peginterferon plus tenofovir disoproxil fumarate in hepatitis D}, journal={Liver International}, year=2024, pages={139-147} }